Showing results (151-160 of 318) with videos related to
Sort By:
Pageof 32
The Clinical Respiratory Journal|December 27, 2018
Small cell lung cancer in the young: Characteristics, diagnosis and outcome dataShiyu Jiang, Xuezhi Hao, Junling Li, et al.Pathology Oncology Research : POR|May 5, 2017
Tumor-Associated Fibroblasts and Microvessels Contribute to the Expression of Immunosuppressive Factor Indoleamine 2, 3-Dioxygenase in Human Esophageal CancersGuanglin Cui, Can Li, Gang Xu, et al.The Journal of Allergy and Clinical Immunology|March 6, 2021
Secreted heat shock proteins control airway remodeling: Evidence from bronchial thermoplastyLei Fang, Junling Li, Eleni Papakonstantinou, et al.Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|June 4, 2019
Sequential therapy according to distinct disease progression patterns in advanced <i>ALK</i>-positive non-small-cell lung cancer after crizotinib treatmentHaiyan Xu, Di Ma, Guangjian Yang, et al.Thoracic Cancer|August 12, 2020
Comparative study of clinicopathological characteristics and prognosis between combined and pure small cell lung cancer (SCLC) after surgical resectionYiying Guo, Lin Yang, Li Liu, et al.Thoracic Cancer|September 7, 2021
Comprehensive analysis of treatment modes and clinical outcomes of small cell lung cancer transformed from epidermal growth factor receptor mutant lung adenocarcinomaShouzheng Wang, Tongji Xie, Xuezhi Hao, et al.Journal of Cancer Research and Clinical Oncology|May 10, 2020
Acquired resistance to osimertinib in patients with non-small-cell lung cancer: mechanisms and clinical outcomesYuxin Mu, Xuezhi Hao, Puyuan Xing, et al.Thoracic Cancer|January 22, 2025
Impact of EML4-ALK Variants and TP53 Status on the Efficacy of ALK Inhibitors in Patients With Non-small Cell Lung CancerZihua Zou, Lige Wu, Xuezhi Hao, et al.Targeted Oncology|May 18, 2020
Heterogeneous Response to First-Generation Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancers with Different EGFR Exon 19 MutationsHaiyan Xu, Weihua Li, Guangjian Yang, et al.Journal of Cancer Research and Clinical Oncology|January 4, 2022
Immune checkpoint inhibitor rechallenge in advanced or metastatic non-small cell lung cancer: a retrospective cohort studyZiyi Xu, Xuezhi Hao, Ke Yang, et al.Pageof 32